Literature DB >> 7537112

CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells.

J Olweus1, F Lund-Johansen, L W Terstappen.   

Abstract

The aim of this study was to identify markers specific for granulo-monocytic commitment of progenitor cells. Large panels of antibodies were screened for selective staining of subsets of CD34+ cells from fetal and adult bone marrow. Flow cytometric analysis showed that CD64/fc gamma RI was undetectable on noncommitted progenitor cells (CD34++, CD38-/lo, HLA-DR+) and expressed on a subset of lineage-committed progenitors (CD34+, CD38+) with higher mean orthogonal light scatter than the remaining CD34+ cells. The CD34+, CD64+ cells were CD19- and the majority were CD45RA+, CD71lo, suggesting that CD64 recognized granulomonocytic progenitor cells. Specificity of CD64 for the granulo-monocytic lineage was shown by demonstrating that colonies arising from CD34+, CD64+ cells consisted of 98% +/- 2% colony-forming unit-granulocyte-macrophage (CFU-GM) in semisolid medium containing stem cell factor (SCF), interleukin-3 (IL-3), IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and erythropoietin (EPO). In contrast, 63% +/- 15% of the colonies from the CD34+, CD64- cells were burst-forming unit-erythroid/colony-forming unit-erythroid (BFU-E/CFU-E). Furthermore, four-color immunofluourescence and cell sorting was used to analyze the progeny of cells cultured in liquid medium containing identical cytokines as used in the semisolid medium. This analysis showed that CD34+, CD64+ cells gave rise to 83% +/- 10% granulo-monocytic cells whereas progeny of the CD34+, CD64- cells contained 81% +/- 11% erythroid cells. Neutrophils as well as basophils and monocytes/macrophages were present in the cultures from CD34+, CD64+ cells, showing that this population contains progenitors of most types of granulo-monocytic cells. Two widely used myeloid markers, CD13 and CD33, were not myeloid-specific, because both were clearly positive on noncommitted progenitor cells. Of 40 antigens tested, CD15 was the only other marker fulfilling the criteria of a myeloid-specific marker. However, at concentrations of CD15 that did not induce aggregation, CD15+ cells constituted less than 50% of the CD34+, CD64+ cells. Furthermore, the CD34+, CD15- cells showed more than 50% higher CD34 mean fluorescence intensity than the CD64+, CD15+ cells, indicating that CD64 appears earlier than CD15 during differentiation. Thus, among a large number of antigens screened, CD64 was the most useful for the identification and purification of granulo-monocytic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537112

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Natural killer-cell differentiation by myeloid progenitors.

Authors:  Bartosz Grzywacz; Nandini Kataria; Niketa Kataria; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2010-12-20       Impact factor: 22.113

2.  FcgammaRIa-gamma-chain complexes trigger antibody-dependent cell-mediated cytotoxicity (ADCC) in CD5+ B cell/macrophage IIA1.6 cells.

Authors:  M J Van Vugt; I E Van den Herik-Oudijk; J G Van de Winkel
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

3.  Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin.

Authors:  J Olweus; A BitMansour; R Warnke; P A Thompson; J Carballido; L J Picker; F Lund-Johansen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

4.  An evolutionary recent IFN/IL-6/CEBP axis is linked to monocyte expansion and tuberculosis severity in humans.

Authors:  Murilo Delgobo; Daniel Agb Mendes; Edgar Kozlova; Edroaldo Lummertz Rocha; Gabriela F Rodrigues-Luiz; Lucas Mascarin; Greicy Dias; Daniel O Patrício; Tim Dierckx; Maíra A Bicca; Gaëlle Bretton; Yonne Karoline Tenório de Menezes; Márick R Starick; Darcita Rovaris; Joanita Del Moral; Daniel S Mansur; Johan Van Weyenbergh; André Báfica
Journal:  Elife       Date:  2019-10-22       Impact factor: 8.140

5.  Impaired growth and elevated fas receptor expression in PIGA(+) stem cells in primary paroxysmal nocturnal hemoglobinuria.

Authors:  R Chen; S Nagarajan; G M Prince; U Maheshwari; L W Terstappen; D R Kaplan; S L Gerson; J M Albert; D E Dunn; H M Lazarus; M E Medof
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

6.  CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors.

Authors:  Federica Calzetti; Giulia Finotti; Nicola Tamassia; Francisco Bianchetto-Aguilera; Monica Castellucci; Stefania Canè; Silvia Lonardi; Chiara Cavallini; Alessandro Matte; Sara Gasperini; Ilaria Signoretto; Fabio Benedetti; Massimiliano Bonifacio; William Vermi; Stefano Ugel; Vincenzo Bronte; Cristina Tecchio; Patrizia Scapini; Marco A Cassatella
Journal:  Nat Immunol       Date:  2022-04-28       Impact factor: 31.250

7.  Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

Authors:  I A Heijnen; M J van Vugt; N A Fanger; R F Graziano; T P de Wit; F M Hofhuis; P M Guyre; P J Capel; J S Verbeek; J G van de Winkel
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow.

Authors:  Huy Q Dinh; Tobias Eggert; Melissa A Meyer; Yanfang Peipei Zhu; Claire E Olingy; Ryan Llewellyn; Runpei Wu; Catherine C Hedrick
Journal:  Immunity       Date:  2020-08-18       Impact factor: 31.745

9.  Prospective isolation of human clonogenic common myeloid progenitors.

Authors:  Markus G Manz; Toshihiro Miyamoto; Koichi Akashi; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

10.  Consistent quantitative gene product expression: #2. Antigen intensities on bone marrow cells are invariant between individuals.

Authors:  Michael R Loken; Andrew P Voigt; Lisa Eidenschink Brodersen; Wayne Fritschle; Andrew J Menssen; Soheil Meshinchi; Denise A Wells
Journal:  Cytometry A       Date:  2016-10-18       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.